Vestal Point Capital »

Janux Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $30M 725k 41.89

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
Adage Capital Partners GP
BlackRock
Henderson Group
Citadel Advisors
Paradigm Biocapital Advisors
Vanguard Group
EcoR1 Capital
State Street Corporation
Cormorant Asset Management
Rtw Investments
Avidity Partners Management
Logos Global Management

View all funds holding Janux Therapeutics